Uterine Sarcoma: Analysis of 13,089 Cases Based on Surveillance, Epidemiology, and End Results Database

International Journal of Gynecological Cancer

Volumn 26, Issue 6, 2016, Pages 1098-1104

  Hosh, Mona ^a   Antar, Sarah ^a   Nazzal, Ahmed ^a   Warda, Mahmoud ^a   Gibreel, Ahmed ^b   Refky, Basel ^b  

^a MANSOURA UNIVERSITY HOSPITAL   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

Epidemiology; Incidence; SEER database; Survival; Uterine sarcoma

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLACK PERSON; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CARCINOSARCOMA; CAUCASIAN; ENDOMETRIUM SARCOMA; FEMALE; HUMAN; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; POST TREATMENT SURVIVAL; PRIORITY JOURNAL; RACE DIFFERENCE; UTERUS SARCOMA; CANCER REGISTRY; INCIDENCE; PROPORTIONAL HAZARDS MODEL; REGISTER; SARCOMA; SARCOMA, ENDOMETRIAL STROMAL; UNITED STATES; UTERINE NEOPLASMS;

ADULT; CARCINOSARCOMA; FEMALE; HUMANS; INCIDENCE; LEIOMYOSARCOMA; PROPORTIONAL HAZARDS MODELS; REGISTRIES; SARCOMA; SARCOMA, ENDOMETRIAL STROMAL; SEER PROGRAM; UNITED STATES; UTERINE NEOPLASMS;

EID: 84977495861     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000720     Document Type: Article

References (22)

1. Nordal RR Thoresen SO. Uterine sarcomas in Norway 1956-1992: incidence, survival, and mortality. Eur J Cancer. 1997; 33: 907-911.
2. Tropé CG Abeler VM Kristensen GB. Diagnosis and treatment of sarcoma of the uterus. A review. Acta Oncol. 2012; 51: 694-705.
3. Genest DR Berkowitz RS Fisher RA World Health Organization Classification of Tumours, Pathology and Genetics, Tumours of the Breast and Female Genital Organs. IARC Press, Lyon, France. 2003: 250-254.
4. Dizon DS Birrer MJ. Advances in the diagnosis and treatment of uterine sarcomas. Discov Med. 2014; 17: 339-345.
5. Brooks SE Zhan M Cote T Surveillance, Epidemiology, and End Results analysis of 2677 cases of uterine sarcoma 1989-1999. Gynecol Oncol. 2004; 93: 204-208.
6. Database: Incidence-SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov 2014 Sub (2000-2012) < Katrina/Rita Population Adjustment >-Linked To County Attributes-Total U.S., 1969-2013 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2015, based on the November 2014 submission. http://seer.cancer.gov/.
7. ICD-0-3 SEER Site/Histology Validation December 5, 2012. 2012;301-496. Available at: http://seer.cancer.gov/icd-o-3/
8. Prat J. FIGO staging for uterine sarcomas. Int J Gynaecol Obstet. 2009; 104: 177-178.
9. Young JJ Roffers S Ries L SEER Summary Staging Manual-2000 Codes and Coding Instructions. Natl Cancer Inst. 2001; NIH Pub. N(01): 118-159. http://seer.cancer.gov/tools/ssm/.
10. Software: Surveillance Research Program, National Cancer Institute SEER∗Stat software. (www.seer.cancer.gov/seerstat) version 8.2.1.
11. Ederer F Axtell LM Cutler SJ. The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr. 1961; 6: 101-121.
12. Felix AS Cook LS Gaudet MM The etiology of uterine sarcomas: a pooled analysis of the epidemiology of endometrial cancer consortium. Br J Cancer. 2013; 108: 727-734.
13. Schwartz SM Weiss NS Daling JR Exogenous sex hormone use, correlates of endogenous hormone levels, and the incidence of histologic types of sarcoma of the uterus. Cancer. 1996; 77: 717-724.
14. Mourits MJ De Vries EG Willemse PH Tamoxifen treatment and gynecologic side effects: a review. Obstet Gynecol. 2001; 97 (5 Pt 2): 855-866.
15. Wysowski DK Honig SF Beitz J. Uterine sarcoma associated with tamoxifen use. N Engl J Med. 2002; 346: 1832-1833.
16. Jaakkola S Lyytinen HK Pukkala E Use of estradiol-progestin therapy associates with increased risk for uterine sarcomas. Gynecol Oncol. 2011; 122: 260-263.
17. Fang Z Matsumoto S Ae K Postradiation soft tissue sarcoma: a multiinstitutional analysis of 14 cases in Japan. J Orthop Sci. 2004; 9: 242-246.
18. Giuntoli RL Metzinger DS DiMarco CS Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol. 2003; 89: 460-469.
19. McCluggage WG. Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas. Int J Gynecol Cancer. 2002; 12: 687-690.
20. D'Angelo E Prat J. Pathology of mixed Müllerian tumours. Best Pract Res Clin Obstet Gynaecol. 2011; 25: 705-718.
21. Ishiko O Wakasa K Honda K Excellent results of postoperative radiotherapy for endometrial stromal sarcoma of low-grade malignancy. Gynecol Obstet Invest. 2000; 49: 214-216.
22. Gadducci A Cosio S Romanini A The management of patients with uterine sarcoma: a debated clinical challenge. Crit Rev Oncol Hematol. 2008; 65: 129-142.